ERBB2 and breast carcinoma: Molecular subtype of breast cancer is determined by the histological analysis of classical markers such as oestrogen and progesterone (ER and PR) receptors, human epidermal growth factor type 2 receptor (HER2), and proliferation index (Ki67) [81].